"The Lancet-Infectious Diseases": Men's HPV vaccine-related infections are reduced by 52%-76%

Although the impact of the human papillomavirus (HPV) vaccine in the female population has received widespread attention, in fact, men who are infected with HPV can also develop cancer

A recent study published in The Lancet Infection Disease found that after the implementation of the HPV vaccination program in schools, the probability of men contracting HPV was reduced by 52% to 76%

The study was led by Professor Eric Chow from Monash University.

The researchers collected anal swabs, penile swabs, and oral rinses from the subjects to test 28 HPV genotypes, and collected population statistics and sexual health behavior data through questionnaire surveys

The results showed that after the quadrivalent vaccine, the infection rate of anal infection of HPV 6, 11, 16 and 18 decreased from 28% to 7%, and the risk of infection was reduced by 76% (corrected prevalence ratio PR=0.

After being vaccinated with the quadrivalent vaccine, the infection rate of the above four subtypes of penile infection dropped from 12% to 6%, and the risk of infection was reduced by 52% (corrected prevalence ratio PR=0.

After being vaccinated with the quadrivalent vaccine, the infection rate of the above four subtypes of oral infection dropped from 4% to 1%, and there were no cases related to type 6 and type 11 infections

Compared with before vaccination, the quadrivalent vaccine can prevent anal and penile infections of any HPV genotype targeted by the vaccine, but oral infections are not reduced

Note: The original text has been deleted

references:

[1] Chow, EP, Tabrizi, SN, Fairley, CK, Wigan, R.

[2] HPV vaccine shows success in gay, bisexual men.